Altamira Therapeutics
CYTO
#10318
Rank
โ‚น96.48 M
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
โ‚น25.53
Share price
0.00%
Change (1 day)
-80.50%
Change (1 year)

EPS for Altamira Therapeutics (CYTO)

EPS in 2019 (TTM): -โ‚น21,375

According to Altamira Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น26,203. In 2018 the company made an earnings per share (EPS) of -โ‚น36,903 an increase over its 2017 EPS that were of -โ‚น1,99,442.

EPS history for Altamira Therapeutics from 2013 to 2019

Annual EPS

Year EPS Change
2019 (TTM)-โ‚น21,375-42.08%
2018-โ‚น36,903-81.5%
2017-โ‚น1,99,442-36.52%
2016-โ‚น3,14,186-5.17%
2015-โ‚น3,31,2997.77%
2014-โ‚น3,07,3990.33%
2013-โ‚น3,06,380